Timing, Fundamentals, and Diversification of Cadrenal Therapeutics Inc (CVKD)

After finishing at $0.64 in the prior trading day, Cadrenal Therapeutics Inc (NASDAQ: CVKD) closed at $0.61, down -4.69%. In other words, the price has decreased by -$0.0268 from its previous closing price. On the day, 52893 shares were traded.

Ratios:

Our goal is to gain a better understanding of CVKD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.27 and its Current Ratio is at 10.27. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Noble Capital Markets on December 18, 2023, initiated with a Outperform rating and assigned the stock a target price of $4.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Oct 05 ’23 when MURPHY JOHN RAYMOND bought 2,669 shares for $0.69 per share. The transaction valued at 1,842 led to the insider holds 614,792 shares of the business.

MURPHY JOHN RAYMOND bought 17,331 shares of CVKD for $12,132 on Oct 04 ’23. The Director now owns 612,123 shares after completing the transaction at $0.70 per share. On Sep 05 ’23, another insider, Pham Quang X, who serves as the CEO and Chairman of the company, bought 40,000 shares for $0.90 each. As a result, the insider paid 36,188 and bolstered with 3,410,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CVKD now has a Market Capitalization of 10.25M and an Enterprise Value of 1.86M.

Stock Price History:

Over the past 52 weeks, CVKD has reached a high of $3.14, while it has fallen to a 52-week low of $0.40. The 50-Day Moving Average of the stock is 0.8871, while the 200-Day Moving Average is calculated to be 0.8290.

Shares Statistics:

The stock has traded on average 351.65K shares per day over the past 3-months and 47.73k shares per day over the last 10 days, according to various share statistics. A total of 13.02M shares are outstanding, with a floating share count of 6.75M. Insiders hold about 57.82% of the company’s shares, while institutions hold 3.45% stake in the company. Shares short for CVKD as of Mar 15, 2024 were 21.91k with a Short Ratio of 0.06, compared to 23.82k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.14% and a Short% of Float of 0.26%.

Earnings Estimates

Its stock is currently analyzed by 2 different market analysts. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.05 and low estimates of -$0.11.

Analysts are recommending an EPS of between -$0.22 and -$0.46 for the fiscal current year, implying an average EPS of -$0.34. EPS for the following year is -$0.32, with 2 analysts recommending between -$0.22 and -$0.42.

Most Popular